NewsRamp
BioVersys announces publication of BV100 Phase 1 data in two leading journals, showing high lung penetration and mild drug interactions, supporting Phase 3 development for CRAB pneumonia.
41 minutes ago
about 1 hour ago
about 1 hour ago
about 1 hour ago
about 1 hour ago
about 2 hours ago
about 2 hours ago
about 3 hours ago
about 3 hours ago
about 3 hours ago
about 3 hours ago
about 4 hours ago
1 day ago
1 day ago
6 days ago
7 days ago
12 days ago
41 minutes ago
about 1 hour ago
about 1 hour ago
about 1 hour ago
about 1 hour ago
4 days ago
4 days ago
5 days ago
7 days ago
7 days ago
41 minutes ago
about 2 hours ago
about 3 hours ago
about 3 hours ago
about 8 hours ago
about 1 hour ago
about 1 hour ago
about 1 hour ago
about 2 hours ago
about 2 hours ago
about 7 hours ago
about 8 hours ago
about 8 hours ago
about 9 hours ago
about 15 hours ago
For newswires & publishers
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
